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Introduction

46
The main aim of Genome-wide association studies (GWASs) is to detect statistically significant 47 multiple categories of SNPs (annotations), SLDSR can also partition h 2 SNP by annotation (h 2 annot ) and 77 thereby provides a way to jointly quantify the enrichment in GWAS signal of several annotations. 78
Here, we extend SLDSR by including annotations containing cis-eQTLs from several tissues, i.e. eQTLs 79 located closely to the gene with which they associate. 16, 17 To this end, we perform analyses based on 80 representative eQTL resources, and consider a variety of traits as outcomes. 81
First, we selected the strongest eQTLs per gene discovered in large samples of measures 82 taken in whole blood and brain. [17] [18] [19] We quantify the contribution of these blood and brain eQTLs to 83 the genetic variance in complex traits captured in GWAS. We then attempt to detect tissue-specific 84 eQTL effects on complex traits by estimating the enrichments of eQTLs uniquely found in whole 85 blood or uniquely found in brain, conditional on the enrichment of the complete blood eQTL 86 annotation or complete brain eQTL annotation, respectively. We consider the effect of eQTLs on 87 three brain-related phenotypes: schizophrenia (MIM: 181500), BMI (MIM: 606641), and educational 88 attainment; three immune disorders: Crohn's disease (MIM: 266600), rheumatoid arthritis (MIM: 89 180300), and ulcerative colitis (MIM: 266600); and five assorted traits and disorders: age at 90 menarche (MIM: 612882), coronary artery disease (MIM: 607339), height (MIM: 606255), LDL levels, 91 and smoking behavior (MIM: 188890). 92
Second, we retrieve all eQTLs identified in any of the 44 tissues from the GTEx consortium. 10 the enrichment of the intersection of cis-eQTLs discovered in any tissue, and histone modification ina specific tissue (i.e. tissue-specific epigenetically changed chromatin states in regulatory regions). 103
Our analyses are designed to elucidate the relation between eQTLs and complex traits, and 104 to quantify the extent to which this relation is dependent on the tissue used in eQTL discovery. Our 105 analysis further considers the enrichment of genomic regions related to gene expression and 106 epigenetically modified in specific tissues. 107 (functional) parts of the genome and used as predictors in a multiple linear regression. 15 
108
Material and Methods
109
SLDSR method
135
Subjects from these studies, not necessarily the same ones, also participated in the GWAS for some 136 of the traits examined. 22, 23, 25, [27] [28] [29] To ensure that the discovery sample did not affect estimates of 137 enrichments of eQTL effects in the various GWAS signals, we looked at trait-specific enrichment of 138 blood and brain eQTL signal in GWAS signal for educational attainment and smoking behavior. We 139 compared the results from using publicly available datasets with using summary statistics based on 140 the same sample without subjects from the NTR or NESDA. The results did not reveal appreciable 141 differences between the respective datasets (S1 Figure) , therefore the remaining analyses for all 142 traits with participants from the NTR or NESDA (age at menarche, BMI, educational attainment, 143 height, LDL level, and smoking behavior) were performed using publicly available summary statistics. 144
145
Blood and brain eQTL enrichment
146
A catalog of whole blood cis-eQTLs was obtained from Jansen et al, 18, 19 where the eQTL most 147 strongly associated with gene expression in whole blood for each probe set was selected for 148 inclusion in our whole blood eQTL annotation. A list of brain eQTLs was obtained from Ramasamy et 149 al, 17 whom studied eQTL effects in 12 distinct brain regions. We included all eQTLs which were found 150 to significantly associate to average gene expression across all 12 brain tissues. SLDSR annotations 151
were constructed as per the instructions of Bulik-Sullivan and Finucane. 36 To guard against upward 152 bias in the eQTL enrichment signal, two extra annotations containing SNPs within a 500 base pair (bp)and 100bp window around any eQTL were constructed for each eQTL set. 15 Finally, to ensure that 154 the enrichment of eQTL effects in GWAS signal was not in fact caused by their proximity to the genes 155 they influence, six additional "gene-centric" annotations were constructed per eQTL set. These 156 annotations included all SNPs that were located in a gene promoter, coding region, or intron and 157 their corresponding 500bp windows that were also within 1Mbp window from any blood or brain 158 eQTL. 159
160
Tissue-specific eQTL enrichment 161 The availability of eQTLs from two tissues allowed for the consideration of eQTLs unique to either 162 blood or brain gene expression, and those that overlap between the two tissues. We modeled the LD 163 between the SNPs of the blood and brain eQTL annotations as a mixture of normal densities. 164
Subsequently, we determined the tissue specificity of each eQTL based on the posterior probability 165 of belonging to a class of SNPS in weak LD with the eQTLs in the other tissue (see appendix A1 for a 166 full model description and results). Based on the split sets of eQTLs, we constructed two additional 167 LD score annotations. The first annotation contained all eQTLs uniquely found in whole blood, and 168 the second contained all eQTLs unique to brain. Here, we assume LD to be a good proxy for the co-169 localization of eQTLs. Strong LD does not guaranty that the blood and brain eQTL in strong LD tag the 170 same underlying causal SNP effect on gene expression. However, given that our research question 171 focuses on genome-wide enrichment, this metric of co-localization between brain and blood eQTLs 172 was the optimal approach. 173
In the presence of tissue-specific eQTL effects, we expect eQTLs unique to a tissue to not be 174 differentially enriched when compared to all eQTLs found in a tissue when the trait is related to that 175 particular tissue (e.g. blood eQTLs are enriched in their effects on rheumatoid arthritis, regardless of 176 their LD with brain eQTLs). We further expect eQTLs unique to a tissue to be depleted in their effect 177 on traits not related to that particular tissue, when compared to eQTLs also found in a trait-relevanttissue (e.g. blood eQTLs are expected to have an effect on educational attainment, but only if theyare in strong LD with brain eQTLs). 180
181
Enrichment of eQTLs from 44 tissues
182
There are two limitations to above mentioned analyses of tissue-specific enrichments of eQTL 183 effects in GWAS signal. First, the eQTLs are obtained from two different projects, which vary in terms 184
of sample size and their definition of an eQTL. Second, both projects identified lead eQTLs (i.e. the 185 statistically strongest eQTL out of many significant eQTL SNPs), which means annotations based on 186 these lists of hits contained a very small portion of the SNPs in the genome, possibly limiting power 187 in SLDSR. To mitigate these limitations, we performed additional analyses using eQTLs obtained by a 188 common pipeline from 44 tissues (see S2 Table) and based on a broader eQTL locus definition. 10 For 189 each of the 44 tissues, we made an annotation for analysis in SLDSR following the previously 190 described procedure. Analogous to the procedure of Finucane et al for cell-type-specific analysis 191 using SLDSR, 15 we additionally made an annotation that contained all GTEx eQTLs, i.e. a SNP would 192 be included in this annotation if it was designated as part of at least one of the 44 tissue-specific 193
GTEx annotations, and added a 100bp and 500bp window. No windows were made for the tissue-194 specific GTEx annotations. Using GWAS summary statistics for schizophrenia, we then ran one SLDSR 195 model containing only the baseline categories and the union of GTEx eQTLs, and 44 additional 196 models with the two previous annotations and one of the tissue-specific GTEx annotations at a time. 197 We repeated the procedure using summary statistics for rheumatoid arthritis. 198
GTEx has relative small sample sizes for the brain eQTL discovery (mean=89 sample size, 199 range=72-103) compared to other tissues (mean=160 sample size, range=70-361). and the corresponding cell-type-specific histone marks. Enrichments in GWAS signal of the 217 intersection should be interpreted as enrichment of genome-wide SNP effects on a complex trait 218 beyond the additive effects which work on all SNPs that are a cis-eQTL and histone mark in question. 219
In fact, we test whether the interaction between tissue-specific chromatin state and eQTLs are 220 enriched in their genome-wide effect on complex traits. 221
222
Results
223
Blood and brain eQTL enrichment 224 We fitted an SLDSR model containing the baseline categories; the complete annotation for both 225 brain and blood eQTL tissues, their 100 and 500bp windows, and gene-centric annotations to all 11 226 GWAS traits (Crohn's disease, rheumatoid arthritis, ulcerative colitis, BMI, educational attainment, 227 schizophrenia, age at menarche, coronary artery disease, height, LDL levels, and smoking behavior). Table) , exceedingenrichments of any of the baseline categories considered by Finucane et al. 15 Additionally, the 231 coding region gene-centric annotation for both blood and brain eQTLs showed considerable 232 enrichment in GWAS signal. Similar to Finucane et al, 15 the average enrichment in the "Enhancer 233
Andersson"-annotation (called "FANTOM5 enhancer" in Finucane et al) is largely determined by the 234 relatively high enrichments of GWAS signal in the three immune-related traits (red dots in Figure 1) . 235
These traits behave similarly in blood eQTLs and its gene-centric annotations, but not in brain eQTLs. 236
Further inspection showed additional differences between the brain and blood eQTL sets in the 237 three immune traits: in these traits, blood eQTLs were roughly 73-113 times enriched in their effect 238 on GWAS signal, but only showed a 21-38-fold enrichment in GWAS signal for brain eQTLs (see S4 239 Table) . The distinction between the two eQTL sets was less prominent for brain-related traits: brain 240 eQTLs were 57 times enriched in their effect on educational attainment, and only showed a 34-37-241 fold enrichment for schizophrenia and BMI. Blood eQTLs showed a 38-45-fold enriched effect. ) and 0.4247 (p=0.004) for schizophrenia and rheumatoid arthritis, respectively. 295
296
Enrichment of the intersection between eQTLs and histone marks 297
We interrogate the intersection of eQTLs and histone marks found in specific CNS and immune cells, 298 and estimate the enrichment of the intersection in its effect on rheumatoid arthritis and 299 schizophrenia. We find significant enrichment in GWAS signal for eQTLs that intersect with histones 300 that bare modification H3K4me1, a modification thought to be present in the enhancer of actively 301 transcribed genes, 37,38 in CNS cells for schizophrenia (see Figure 3) . The results are further 302 idiosyncratic in that there is some evidence for significant enrichment of eQTLs that intersect with 303 immune cells baring the H3K4me1 mark in their effect on schizophrenia, but not on rheumatoid 304
arthritis. Specifically, none of the intersecting annotations show evidence of enrichment for 305 rheumatoid arthritis. For the separate annotations, we find significant enrichment in GWAS signal 306 across all histone marks found in CNS cells and three significant immune cell-types that bare theH3K4me3 modification, a modification associated with transcriptional start sites and promoters ofactively transcribed genes, 37,38 for schizophrenia (S7 Figure) . The opposite picture was seen for 309 rheumatoid arthritis: a wide variety of immune-cell specific histone marks showed significant 310 enrichments in GWAS signal, while all marks found in CNS cells were below zero. The union of GTEx 311 eQTLs reached statistical significance for all models (S8 Figure) . showed that eQTLs were substantially stronger enriched in their effect on complex traits compared 320 to all categories considered by Finucane et al. 15 The complete brain eQTL annotation was 321 significantly enriched in GWAS signal for BMI and schizophrenia, and was consistent with previous 322 estimates of eQTL effect enrichment.
8 Considerable enrichment for eQTLs, even for traits not 323 apparently linked to the brain or immune system (e.g. coronary artery disease), suggested that non-324 trivial eQTL overlap across tissues might be present. 325
Inclusion of both brain and blood eQTLs into the SLDSR model did not fully separate the 326 signal into tissue-specific effects, as shown by the roughly equal enrichments of both annotations 327 within brain-related traits. Using LD scores to inform a mixture-based separation of the eQTL sets 328 yielded an incomplete separation of tissue-specific enrichment. In general, we are not able to clearly 329 identify tissue-specific eQTL signals using these datasets and SLDSR. Our second analysis of eQTL 330 enrichment based on 44 tissue-specific cis-eQTL sets, obtained from the GTEx consortium, confirms 331 the lack of tissue-specific eQTL enrichment. While an annotation containing all eQTLs identified inrespectively, both p<0.001), none of the analyzed brain tissues are enriched beyond all eQTLs intheir effect on schizophrenia. Similarly, whole blood eQTLs are not significantly enriched beyond all 335
GTEx eQTLs taken together in their effect on rheumatoid arthritis. Again, these findings are not 336 consistent with the hypothesis of abundant tissue-specific eQTLs with effects on complex traits 337 related to the specific tissue in question. Especially, when contrasted with tissue-specific gene 338 expression levels and tissue-specific histone modifications, 13,39 tissue-specific eQTLs are of limited 339 value in relating complex traits to a tissue. We do, however, find evidence for possible enrichment 340 for eQTLs that intersect with tissue-specific H3K4me1 histone marks in the brain, but also immune 341 cells, in their effect on schizophrenia but not rheumatoid arthritis. This means that eQTLs in 342
H3k4me1 marks are enriched in their effect on schizophrenia above the expected enrichment based 343 on the fact that these SNPs are both eQTLs and located in H3K4me1 histone marks. What is of 344 substantial interest is that the enrichment in GWAS signal appears specific to H3K4me1 marks, 345
suggesting that these marks specifically can aid in prioritizing genomic regions in which tissue-346 specific eQTLs may reside. Though, again, the totality of evidence is inconclusive on the relevance of 347 tissue-specific eQTLs to variation in complex traits. 348
Our results are consistent with, and complimentary to, a study investigating the genetic 349 correlation between gene expression levels across 15 tissues. 13 This study revealed substantial 350 correlations between cis-genetic effects on gene expression across 15 tissues. 13 Our analyses confirm 351 the value of using whole blood as discovery tissue for detection of eQTLs and further demonstrate 352 the usefulness of techniques that use eQTLs discovered in whole blood to study the etiology of 353 complex traits related to different tissues. 40, 41 The results presented here highlight the overlap of cis-354 eQTL effects across tissues on a genome-wide level. However, the effect of a cis-eQTL might vary 355 substantially across tissues for individual genes. 42 Our conclusions are based on genome-wide 356 enrichments and therefore should not be interpreted as limited evidence for tissue-specific eQTL 357 effects for individual genes. Therefore, eQTL discovery in the tissue most relevant to a specific trait 358 or disorder remains important to further our understanding of the genetic regulation of tissuespecific gene expression. What is also clear is that to find those tissue-specific eQTLs that are ofrelevance to the interpretation of GWASs of complex traits, tissue-specific eQTL discovery needs to 361 be refined. The practice of, as a post-hoc analysis to GWAS, performing eQTL lookup in a specific 362 tissue linked to a trait, when larger dataset for other accessible tissues are available may be sub 363 optimal. In fact one may prefer to perform a lookup in the overlap between epigenetic modifications 364 in a relevant tissue and eQTLs regardless of tissue. One can further consider utilizing eQTLs to link 365 GWAS findings to a gene, and subsequently consider the differential expression of a gene to identify 366 the tissue in which the gene is most likely to act in effecting the trait. Tissue-specific differential gene 367 expression vastly outperforms eQTLs in tagging regions of the genome enriched in their effect on 368 complex traits. We attempted to separate the signal from all blood eQTLs collectively by looking at the degree of LD 380 each blood eQTL has with all brain eQTLs. Fig A1 shows the distribution of LD scores for all blood 381 eQTLs. A strong mass can be seen around 0 LD (eQTLs unique to whole blood) with a long tail to the 382 right (blood eQTLs in [strong] LD with one or more brain eQTL[s]). To determine the cutoff valueapproximates the distribution of the LD scores using a mixture of a user-defined number of normaldistributors. Based on their posterior probabilities, each eQTL is then assigned to one of the 387 distributors. A five-class normal mixture distribution returned two components with a mean of 388 roughly zero and three components that clearly deviated from zero (Table A) . Fitting more than five 389 mixture classes did not result in an appreciable different separation of blood eQTLs with near zero 390 LD with brain eQTLs. Therefore, the results from fitting a five-class mixture were used to make the 391 distinction, where the SNPs that had the highest posterior probability of belonging to one of the 392 components with a mean LD near zero, i.e. the first two components, were considered unique blood 393 eQTLs. Fig A2 shows the distribution of LD scores for brain eQTLs. Again, a strong mass around zero 394 with a long tail to the right can be seen and fitting a mixture of five normal distributors resulted in 395 optimal separation of unique brain eQTLs and brain eQTLs in (strong) LD with blood eQTLs (Table B) . 396
SNPs with the highest posterior probability of belonging to the first two components were 397 categorized as unique brain eQTLs. 
